{"id":29409,"date":"2014-08-25T11:18:56","date_gmt":"2014-08-25T15:18:56","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=29409"},"modified":"2014-08-25T11:18:56","modified_gmt":"2014-08-25T15:18:56","slug":"pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409","title":{"rendered":"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/25\/2014 (wallstreetpr) \u2013 It seems <strong>Pfizer Inc. (NYSE:PFE)<\/strong> is adamant for an overseas takeover to get the tax inversion benefits and expand its product portfolio. It can place a renew <a href=\"http:\/\/www.bloomberg.com\/news\/2014-08-20\/astrazeneca-is-tougher-target-for-possible-new-pfizer-bid.html\" target=\"_blank\">bid<\/a> for <strong>AstraZeneca plc (ADR) (NYSE:AZN)<\/strong>, on November 26, 2014. But if AstraZeneca wants, it can invite Pfizer for further discussion after August 25, 2014. Pfizer is also considering the other acquisition options including <strong>Actavis plc Ordinary Shares (NYSE:ACT)<\/strong>.<\/p>\n<p style=\"text-align: justify;\"><strong>The persistent efforts<\/strong><\/p>\n<p style=\"text-align: justify;\">Initially, Pfizer Inc. (NYSE:PFE) has offered a $116 billion bid to acquire AstraZeneca. The bid was cancelled on May 26, and as per the U.K. takeover rules, Pfizer can bid for AstraZeneca again after six months on November 26. AstraZeneca rejected the bid offer of Pfizer on the basis of low valuation. Pfizer has offered 55 pounds a share as offer price whereas AstraZeneca asked for minimum 58.85 pounds a share for the final deal. The deal price of 58.85 pounds a share is considered as a high offer price for AstraZeneca.<\/p>\n<p style=\"text-align: justify;\"><strong>The offer price<\/strong><\/p>\n<p style=\"text-align: justify;\">The company has got solid pipeline of experimental drugs. It has instilled a confidence in the board to seek a higher offer price. AstraZeneca plc (ADR) (NYSE:AZN) plans to spend around $2.1 billion for bringing in new respiratory treatments. Also, it expects to achieve successful trial results of its three cancer-medicines. If it happens, AstraZeneca can get a healthy market share in the industry.<\/p>\n<p style=\"text-align: justify;\"><strong>The interest<\/strong><\/p>\n<p style=\"text-align: justify;\">Pfizer Inc. (NYSE:PFE) is looking for a deal that will results in cost reductions for the company. Also, it wants to achieve lower tax rates and get access to overseas cash. Pfizer will consider the product pipeline of AstraZeneca, who has got 15 drugs in final trials or waiting for regulatory approval. The experimental drugs have doubled in number from a year ago. Pfizer Inc. (NYSE:PFE) will evaluate all the existing opportunities and will select the company that can create long-term value for its shareholders.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/25\/2014 (wallstreetpr) \u2013 It seems Pfizer Inc. (NYSE:PFE) is adamant for an overseas takeover to get the tax inversion benefits and expand its [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":22248,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[8347,4659,7028,4503,2048,4504,993,2745,3275],"stock_ticker":[],"class_list":["post-29409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-actavis-plc-ordinary-shares","tag-actavis-plc-ordinary-shares-nyseact","tag-astrazeneca-plc-adr","tag-astrazeneca-plc-adr-nyseazn","tag-nyseact","tag-nyseazn","tag-nysepfe","tag-pfizer-inc-nysepfe","tag-pfizer-inc","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)  - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)  - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/25\/2014 (wallstreetpr) \u2013 It seems Pfizer Inc. (NYSE:PFE) is adamant for an overseas takeover to get the tax inversion benefits and expand its [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-25T15:18:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"284\" \/>\n\t<meta property=\"og:image:height\" content=\"177\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)\",\"datePublished\":\"2014-08-25T15:18:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\"},\"wordCount\":328,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"keywords\":[\"Actavis plc Ordinary Shares\",\"Actavis plc Ordinary Shares (NYSE:ACT)\",\"AstraZeneca plc (ADR)\",\"Astrazeneca Plc (ADR) (NYSE:AZN)\",\"NYSE:ACT\",\"NYSE:AZN\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\",\"Pfizer Inc.\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\",\"name\":\"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"datePublished\":\"2014-08-25T15:18:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg\",\"width\":284,\"height\":177},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)  - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409","og_locale":"en_US","og_type":"article","og_title":"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)  - Wall Street PR","og_description":"Boston, MA 08\/25\/2014 (wallstreetpr) \u2013 It seems Pfizer Inc. (NYSE:PFE) is adamant for an overseas takeover to get the tax inversion benefits and expand its [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-25T15:18:56+00:00","og_image":[{"width":284,"height":177,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)","datePublished":"2014-08-25T15:18:56+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409"},"wordCount":328,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","keywords":["Actavis plc Ordinary Shares","Actavis plc Ordinary Shares (NYSE:ACT)","AstraZeneca plc (ADR)","Astrazeneca Plc (ADR) (NYSE:AZN)","NYSE:ACT","NYSE:AZN","NYSE:PFE","Pfizer Inc (NYSE:PFE)","Pfizer Inc."],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409","name":"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","datePublished":"2014-08-25T15:18:56+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Pfizer-Inc..jpg","width":284,"height":177},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-can-raise-its-bid-for-astrazeneca-plc-adr-nyseazn-29409#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/29409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=29409"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/29409\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/22248"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=29409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=29409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=29409"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=29409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}